Core Insights - The China Securities Regulatory Commission (CSRC) disclosed that four companies have recently received approval for overseas issuance and listing [1] Group 1: Companies Involved - Huichuang Electronics Co., Ltd. plans to issue up to 10.4 million ordinary shares and list on the Taiwan Stock Exchange [1] - Nobikang Artificial Intelligence Technology (Chengdu) Co., Ltd. intends to issue up to 4.35455 million ordinary shares and list on the Hong Kong Stock Exchange [1] - Meilian Steel Structure Building System (Shanghai) Co., Ltd. aims to issue up to 36.7803 million ordinary shares for listing on the Hong Kong Stock Exchange [1] - Hansai Aitai Biopharmaceutical Technology (Wuhan) Co., Ltd. plans to issue up to 21.0697 million ordinary shares and list on the Hong Kong Stock Exchange [1] Group 2: Share Conversion - Nobikang has 33 shareholders who plan to convert a total of 26,647,978 shares of unlisted domestic shares into H-shares [1] - Meilian has 13 shareholders intending to convert a total of 95,950,005 shares of unlisted domestic shares into H-shares [1] - Hansai Aitai has 15 shareholders who plan to convert a total of 117,897,830 shares of unlisted domestic shares into H-shares [1]
本周新增辉创电子、美联股份等4家境外上市备案企业
Sou Hu Cai Jing·2025-11-16 09:33